(Q36433925)

14 August 2017

Report on nationwide pooled data and cohort investigation in UFT phase II study. (English)

1 reference

14 August 2017

K Ota

1

1 reference

PubMed ID

3139315

14 August 2017

T Taguchi

series ordinal

2

1 reference

PubMed ID

3139315

14 August 2017

K Kimura

series ordinal

3

1 reference

14 August 2017

1 January 1988

1 reference

Cancer Chemotherapy and Pharmacology

14 August 2017

1 reference

14 August 2017

22

1 reference

14 August 2017

4

1 reference

14 August 2017

333-338

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00254241

14 August 2017

0 references

cites work

Studies on fluorinated pyrimidines. IX. The degradation of 5-fluorouracil-6-C14

1 reference

12 December 2020

[A randomized trial of adriamycin, cyclophosphamide, ftorafur (ACF) and adriamycin, cyclophosphamide, ftorafur, methotrexate (ACFM) in patients with advanced breast cancer]

1 reference

12 December 2020

Effect of uracil and its derivatives on antitumor activity of 5-fluorouracil and 1-(2-tetrahydrofuryl)-5-fluorouracil

1 reference

12 December 2020

Potentiation of the teratogenic effects of 5-fluorouracil by natural pyrimidines. II. Biochemical aspects

1 reference

12 December 2020

Clinical basis of chemotherapy for gastric cancer with uracil and 1-(2'-tetrahydrofuryl)-5-fluorouracil

1 reference

12 December 2020

Comparison of pharmacokinetics of 5-fluorouracil and 5-fluorouracil with concurrent thymidine infusions in a Phase I trial

1 reference

12 December 2020

Effect of coadministration of uracil or cytosine on the anti-tumor activity of clinical doses of 1-(2-tetrahydrofuryl)-5-fluorouracil and level of 5-fluorouracil in rodents

1 reference

12 December 2020

Growth inhibition of a human tumor cell strain by 5-fluorouracil, 5-fluorouridine, and 5-fluoro-2'-deoxyuridine; reversal studies

1 reference

12 December 2020

[Results of phase III study of lentinan]

1 reference

12 December 2020

Effect of uracil on metabolism of 5-fluorouracil in vitro

1 reference

12 December 2020

5-Fluorouracil and derivatives in cancer chemotherapy. 3. In vivo enhancement of antitumor activity of 5-fluorouracil (FU) and 5-fluoro-2'-deoxyuridine (FUDR)

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00254241

1 reference

14 August 2017

1 reference

PubMed ID

3139315